Getting More Out of Diabetes Technology — with Diabetech
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
概要
Are you getting the most out of the diabetes technology you use every day and do you know what’s coming next?
In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus sit down with diabetes tech expert Justin Eastzer, creator of Diabetech, who is also living with type 1 diabetes, for a conversation about the steadily growing and expanding world of diabetes technology. They talk about how CGMs, automated insulin delivery systems, connected apps, and wearable displays are continuing to improve the way people with type 1 diabetes manage glucose in daily life.
Justin shares his diagnosis story, including being initially treated for type 2 diabetes before learning he had type 1, and how the online diabetes community helped him find the right answers. That experience led him to build a platform dedicated to reviewing devices, following industry developments, and helping people better understand the technology available today.
The discussion explores the current landscape of automated insulin delivery systems, practical differences between pumps, and the growing ecosystem of apps, displays, and data tools that allow people to interact with their glucose data in real time. They also look ahead at what’s coming next in diabetes tech, including new pump designs, smarter algorithms, improved connectivity, and continued efforts to reduce the day-to-day workload of living with type 1 diabetes.
Key Topics
• Why many people only use part of their diabetes tech’s capabilities
• Justin’s journey to a type 1 diabetes diagnosis
• Making pumps, CGMs, and apps work in everyday life
• Comparing automated insulin delivery systems
• Tubed vs. tubeless pump considerations
• The importance of optimizing personal settings
• Progress over perfection with time in range
• Reducing diabetes burnout through technology
• Helpful apps, displays, and tech hacks
• Where diabetes technology is heading next